This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Crimi, E Articles by Bontempo, P Search for Related Content PubMed Articles by Crimi, E Articles by Bontempo, P Social Bookmarking                         What's this?

The Beneficial Effects of Antioxidant Supplementation in Enteral Feeding in Critically Ill Patients: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial

Department of Anesthesiology and Intensive Care, University of Eastern Piedmont, Novara, Italy; Coronary Care Unit, Pellegrini Hospital, Naples, Italy; Department of Medicine, University of Naples, Naples, Italy; Division of Clinical Pathology, II University of Naples, Naples, Italy; and the Department of Anesthesiology and Intensive Care, University of Catania, Catania, Italy

We investigated whether intervention with antioxidant vitamins C and E in enteral feeding influenced oxidative stress and clinical outcome in critically ill patients. Two-hundred sixteen patients expected to require at least 10 days of enteral feeding completed the study. One-hundred five patients received enteral feeding supplemented with antioxidants, and 111 control patients received an isocaloric formula. Plasma lipoperoxidation (by thiobarbituric acid reactive substances [TBARS] and prostaglandin F₂ isoprostane levels), low-density lipoprotein (LDL) oxidizability, and LDL tocopherol content were determined at baseline and at the end of the 10-day period. The clinical 28-day outcome was also assessed. Plasma TBARS and isoprostanes were 5.33 ± 1.26 nM/mL and 312 ± 68 pg/mL, respectively, before treatment and 2.42 ± 0.61 nM/mL and 198 ± 42 pg/mL after intervention (p < .01 for both comparisons). Antioxidants improved LDL resistance to oxidative stress by approximately 30% (the lag time before treatment was 87 ± 23 minutes and was 118 ± 20 minutes after treatment; p < .04). There was a significantly reduced 28-day mortality after antioxidant intervention (45.7% in the antioxidant group and 67.5% in the regular-feeding group; p < .05). Isoprostanes may provide a sensitive biochemical marker for dose selection in studies involving antioxidants.

Nutrition in Clinical Practice, Vol. 20, No. 3, 363-364 (2005)
DOI: 10.1177/0115426505020003363


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?